Skip to content

APOTHEEK THIELEN

Active
Private limited companyfounded 2008active for 18 yearsKerkstraat(SGW) 42, 9170 Sint-Gillis-Waas, BelgiumKBO/BCE: BE 0897.786.369
Summary

APOTHEEK THIELEN has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €315,840 and a net result of €81,820. Equity is shrinking by about 6.9% per year across the filed financial years. Its solvency ranks better than 79% of 12,686 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
APOTHEEK THIELENActiveChecked score 97/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
≈ €1.1mturnover 2025, estimated
Staff
3.1 FTE
Equity
€315,840
Profit
€81,820
Turnover estimated from the gross margin
Financial health
97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Parent
GLORIELLE · 100%
2025 accounts filed 28 days late5 deeds in the Belgian Official Gazette
Why 97raises riskSize: 3.1 FTE, total assets €470,532lowers riskLiquidity: current ratio 2.95, cash €103,270Equity €315,840 (67.1% of total assets)Founded in 2008Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 74% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 92+9
equity 67.1% of total assets
Liquidity 63-15
short-term debt 32.9% · cash 21.9%
Profitability 90+6
return on assets 17.4%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,259 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026highest value 09-2026: 0.1%▼ -0.1 percentage points vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026lowest value
Credit of up to €30,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.95, compared with 2.34 in 2024, above the usual 1.5; short-term debt: 32.9% and cash: 21.9% of total assets), and 32.9% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 79% on solvency, 70% on liquidity, 85% on profitability and 62% on growth.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 2.95, cash €103,270
NBB · annual accounts
lowers risk · Equity €315,840 (67.1% of total assets)
NBB · annual accounts
lowers risk · Founded in 2008
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Size: 3.1 FTE, total assets €470,532
Companies of this size fail more often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €315,840
neutral · A punctual record breaks
This company filed 6 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are now bankrupt, dissolved or in another special legal status, below the 1.66% of all filers. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filings
Deviation from the deadline
2025
28 days late
2024
38 days early
2023
36 days early
2022
41 days early
2021
40 days early
2020
30 days early
2019
17 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 25 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 23 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
29-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Annual accounts filedfinancial year 2023 · abbreviated…

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €81,820 8 years View
  • Controlled by GLORIELLE 100% View
  • Total assets 20256 financial years filed €470,532 View

By topic

Financials

Financial year
2025
Total assets
€470,532
Profit
€81,820
Solvency
67.1%
Total assets▼ 3.7%
Net result
20182025
Go to Financials

Timeline

Events
19
Since
2010
Next accounts
by 31-07-2027
  1. 20-06-2023Annual accounts filed
  2. 31-12-2022Highest result from 2018 to 2025
  3. 21-06-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
08-05-2008
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about APOTHEEK THIELEN

What is the company number of APOTHEEK THIELEN?
0897.786.369. In Belgium the VAT number is the company number with BE in front: BE 0897.786.369.
Where is APOTHEEK THIELEN based?
The registered office is at Kerkstraat(SGW) 42, 9170 Sint-Gillis-Waas.Company details
What does APOTHEEK THIELEN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK THIELEN?
Private limited company (BV).
When was APOTHEEK THIELEN founded?
On 08-05-2008.
Is APOTHEEK THIELEN still active?
Yes, APOTHEEK THIELEN is an active enterprise in the KBO register.
How many employees does APOTHEEK THIELEN have?
On average 3.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK THIELEN?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is APOTHEEK THIELEN profitable?
In financial year 2025, APOTHEEK THIELEN made a profit of €81,820.
Where can I find the annual accounts of APOTHEEK THIELEN?
APOTHEEK THIELEN filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK THIELEN due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to APOTHEEK THIELEN

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure